Dersimelagon

Star0

DB18007InvestigationalSmall molecule

Dersimelagon: Overview.

Mechanism: Pharmacologically active on Melanocyte-stimulating hormone receptor
Curator reviewed
Formula / weight: C₃₆H₄₅F₄N₃O₅ · 675.766 g/mol (avg)
Also known as: 1-(2-((3s,4r)-1-((3r,4r)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)pyrrolidine-3-carbonyl)-4-(methoxymethyl)pyrrolidin-3-yl)-5-(trifluoromethyl)phenyl)piperidine-4-carboxylic acid · 4-piperidinecarboxylic acid, 1-(2-((3s,4r)-1-(((3r,4r)-1-cyclopentyl-3-fluoro-4-(4-methoxyphenyl)-3-pyrrolidinyl)carbonyl)-4-(methoxymethyl)-3-pyrrolidinyl)-5- (trifluoromethyl)phenyl)-
Code names: MT-7117

Resolves to

Compound

UNII1CWH5SV4G2CAS1835256-48-8ChEMBLCHEMBL4802160

Structure

InChIKeyMUNWOYRHJPWQNE-GMFUQMJFSA-NSMILESCOC[C@H]1CN(C[C@@H]1C1=CC=C(C=C1N1CCC(CC1)C(O)=O)C(F)(F)F)C(=O)[C@]1(F)CN(C[C@H]1C1=CC=C(OC)C=C1)C1CCCC1

Targets

Q01726MC1R

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dersimelagon, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account